Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation by Riley Nolan | May 13, 2021
Identification of a potent regulatory T cell epitope infactor V that modulates CD4+ and CD8+ memory T cell responses by Annie De Groot | Jan 13, 2021FV621 De Groot et al 2021
T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 by Annie De Groot | Jun 30, 20202020 TCWP
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools by Annie De Groot | Apr 13, 2020Better Epitope Discovery, De Groot et.al. 2020
T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines by Annie De Groot | Apr 9, 20202020 Bandrick et al. EpiCC